Cover Image

Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill® via ameliorate of multiple mitochondrial dysfunctions

Jing Rui Chen,1–3 Jing Wei,1–3 Ling Yan Wang,1–3 Yan Zhu,1–3 Lan Li,1–3 Mary Akinyi Olunga,1–3 Xiu Mei Gao,1–3 Guan Wei Fan1–31Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin, People’s Republic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chen JR (Author), Wei J (Author), Wang LY (Author), Zhu Y (Author), Li L (Author), Olunga MA (Author), Gao XM (Author), Fan GW (Author)
Format:	Book
Published:	Dove Medical Press, 2015-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
by: Shichao Lv, et al.
Published: (2022)

Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
by: Jun Zhang, et al.
Published: (2022)

UHPLC-Q-Orbitrap HRMS and network analysis to explore the mechanisms of QiShenYiQi dripping pill for treating myocardial infarction
by: Zhichao Liu, et al.
Published: (2024)

QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats
by: Congyang Ding, et al.
Published: (2022)

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
by: Jun Zhang, et al.
Published: (2022)

Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model
by: Yule Wang, et al.
Published: (2021)

QiShenYiQi Inhibits Tissue Plasminogen Activator-Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
by: Yang Ye, et al.
Published: (2022)

QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway
by: Gulinigaer Anwaier, et al.
Published: (2022)

The modified Yi qi decoction protects cardiac ischemia-reperfusion induced injury in rats
by: Xiao Yu, et al.
Published: (2017)

Uncovering the mechanisms of Yi Qi Tong Qiao Pill in the treatment of allergic rhinitis based on Network target analysis
by: Boyang Wang, et al.
Published: (2023)

Exploring the Mechanisms of Modified Bu-Shen-Yi-Qi Decoction for COPD-Related Osteoporosis Therapy via Transcriptomics and Network Pharmacology Approach
by: Zhong Y, et al.
Published: (2023)

ShenQiWan ameliorates renal injury in type 2 diabetic mice by modulating mitochondrial fusion and endoplasmic reticulum stress
by: Wei Xiong, et al.
Published: (2023)

YiQiFuMai powder injection ameliorates blood–brain barrier dysfunction and brain edema after focal cerebral ischemia–reperfusion injury in mice
by: Cao GS, et al.
Published: (2016)

Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
by: Yuanyuan Zhong, et al.
Published: (2022)

Yi Qi Jie Du Decoction Inhibits Proliferation and Induces Apoptosis of Nasopharyngeal Carcinoma Stem Cells Through Mitochondrial Apoptosis Pathway
by: Zhou Fang-Liang, et al.
Published: (2019)

Investigation of the hypoglycemic mechanism of the ShenQi compound formula through metabonomics and 16S rRNA sequencing
by: Juan Gao, et al.
Published: (2024)

Qi stagnation and qi deficiency are associated with depression in college students
by: Wang Xinzhu, et al.
Published: (2024)

ShenQi FuZheng injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis
by: Hongbo Zhang, et al.
Published: (2019)

Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
by: Xinhui Liu, et al.
Published: (2018)

The chemical components, action mechanisms, and clinical evidences of YiQiFuMai injection in the treatment of heart failure
by: Shichao Lv, et al.
Published: (2022)

Pediatric Quality Improvement (QI) Virtual Practicum: Adapting a QI Simulator
by: Celia Greenlaw, et al.
Published: (2020)

QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
by: Meng Li, et al.
Published: (2022)

Qi, Return to Bodily Experience: A New Perspective of Qi and Qigong Experience Research
by: Xinzhe Huang
Published: (2020)

Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
by: Qiaoru Wu, et al.
Published: (2022)

Protective Effects and Active Ingredients of Yi-Qi-Fu-Mai Sterile Powder Against Myocardial Oxidative Damage in Mice
by: Yu-Qing Wang, et al.
Published: (2013)

Jin-Gui-Shen-Qi Wan ameliorates diabetic retinopathy by inhibiting apoptosis of retinal ganglion cells through the Akt/HIF-1α pathway
by: Dan Liang, et al.
Published: (2023)

The Effectiveness and Safety of Yi Shen Juan Bi Pill on Rheumatoid Arthritis: a Protocol for Systematic Review and/or Meta-Analysis
by: Gyoungeun Park, et al.
Published: (2024)

Kampo formula hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang, TJ-41) ameliorates muscle atrophy by modulating atrogenes and AMPK in vivo and in vitro
by: Mitsutaka Yakabe, et al.
Published: (2022)

Yi Shen Juan Bi Pill Ameliorates Bone Loss and Destruction Induced by Arthritis Through Modulating the Balance of Cytokines Released by Different Subpopulations of T Cells
by: Hongyan Zhao, et al.
Published: (2018)

Network pharmacology and experimental evidence reveal the protective mechanism of Yi-Qi Cong-Ming decoction on age-related hearing loss
by: Yi-Fang Yang, et al.
Published: (2022)

Mechanism of action of Bu Zhong Yi Qi Decoction in the treatment of chronic fatigue syndrome based on network pharmacology and molecular docking
by: Jie Zhang, et al.
Published: (2022)

Huang Qi Tong Bi Decoction Attenuates Myocardial Ischemia-Reperfusion Injury via HMGB1/TLR/NF-κB Pathway
by: Kun Liu, et al.
Published: (2019)

Target Identification of Active Constituents of Shen Qi Wan to Treat Kidney Yang Deficiency Using Computational Target Fishing and Network Pharmacology
by: Jie Ying Zhang, et al.
Published: (2019)

Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4+ type 9 helper T cells and the VIP-VPAC2 signalling pathway
by: Muhua Huang, et al.
Published: (2021)

On the qi deficiency in traditional Chinese medicine
by: Hui-Chu Chiang, et al.
Published: (2014)

Yi Shen Juan Bi Pill Regulates the Bone Immune Microenvironment via the JAK2/STAT3 Signaling Pathway in Vitro
by: Ya Xia, et al.
Published: (2021)

Ren-Shen-Bu-Qi decoction alleviates exercise fatigue through activating PI3K/AKT/Nrf2 pathway in mice
by: Yangyang Chen, et al.
Published: (2024)

Using the QI Maturity Tool - Modified Ontario Version to assess the state of QI maturity in Ontario's public health units
by: Madelyn P. Law, et al.
Published: (2021)

Yi Shen Juan Bi Pill alleviates bone destruction in inflammatory arthritis under postmenopausal conditions by regulating ephrinB2 signaling
by: Huihui Xu, et al.
Published: (2022)

The Cardioprotective Effect of Protocatechuic Acid on Myocardial Ischemia/Reperfusion Injury
by: Xi-Lan Tang, et al.
Published: (2014)